Stocks · Healthcare · Drug Manufacturers - General
Amgen Inc. AMGN
$403.04 -1.04% Close, Oct 2, 2026 · NASDAQ · Market cap $217.52B
High qualityLow risk
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to 33.2% from 23.4% a year earlier.
- Earnings beat analyst estimates in each of the last 8 quarters (average surprise over the last four: +11.0%).
- The stock is in an uptrend: above its 200-day average for 85 trading days, with the 50-day average above the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth54Neutral
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 50%
- EPS growth (TTM, YoY)Top 34%
- FCF growth (TTM, YoY)Bottom 38%
- Revenue growth, 3-year CAGRTop 46%
- Revenue growth accelerationTop 43%
Quality83Strong
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 9%
- Gross marginTop 40%
- Operating marginTop 5%
- Cash conversion (OCF / net income)Bottom 43%
- Accruals (lower is better)Bottom 34%
- Net debt / EBITDA (lower is better)Bottom 34%
- Interest coverTop 26%
Value71Positive
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 14%
- Free-cash-flow yieldTop 19%
- EBITDA / enterprise valueTop 19%
- Sales / enterprise valueBottom 39%
- P/E vs own 5-year history (lower is better)Bottom 28%
Momentum77Positive
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 34%
- 6-month returnTop 43%
- 1-year return vs S&P 500Top 33%
- Distance from 52-week highTop 15%
- Trend checklist (0–4)Top 20%
Revisions39Weak
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 36%
- Consecutive EPS beatsTop 8%
- Share of analysts rating BuyBottom 19%
- Upside to consensus price targetBottom 10%
Stability89Strong
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 16%
- Maximum drawdown, 3 yearsTop 1%
- Beta vs S&P 500 (lower is better)Top 10%
- Net debt / EBITDA (lower is better)Bottom 34%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 9.1% | 9.2% | ↑ |
| EPS growth (YoY) | 31.1% | 31.6% | ↑ |
| Gross margin | 64.5% | 72.7% | ↑ |
| Operating margin | 23.4% | 33.2% | ↑ |
| FCF margin | 30.4% | 26.7% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 9.2% | 9.1% | ↑ | Top 50% |
| EPS growth (TTM, YoY) | 31.6% | 31.1% | ↑ | Top 34% |
| Gross margin | 72.7% | 64.5% | ↑ | Top 40% |
| Operating margin | 33.2% | 23.4% | ↑ | Top 5% |
| Net margin | 22.9% | 19.0% | ↑ | — |
| Free-cash-flow margin | 26.7% | 30.4% | ↓ | — |
| Return on invested capital | 14.2% | — | Top 9% | |
| Revenue growth, 3-year CAGR | 11.8% | — | Top 46% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.43×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 0.7%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +8.3 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 2.62×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 4.7×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 2.43%
- Net buyback yield (TTM)
- 0.00%
- Shareholder yield
- 2.43%
- Share count change, 1 year
- +0.6%
- Share count change, 3-year CAGR
- +0.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 8
- Beats in the last 8 reports
- 8 of 8
- Average EPS surprise, last 4
- +11.0%
- Average 2-day reaction, last 8
- +0.1%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $397.21
- Target vs current price
- -1.4%
- Analysts with a rating
- 41
- Share rating Buy or Strong Buy
- 54%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | +11.9% | +2.9% | +10.1% | +13.5% | — |
| Apr 30, 2026 | +8.0% | +2.4% | -2.0% | -0.5% | +11.3% |
| Feb 3, 2026 | +11.8% | -1.8% | +9.0% | +9.4% | -1.9% |
| Nov 4, 2025 | +12.4% | +0.1% | +9.2% | +14.2% | +15.4% |
| Aug 5, 2025 | +14.0% | -0.6% | -5.6% | -5.0% | -3.3% |
| May 1, 2025 | +14.8% | -2.5% | -5.2% | -2.5% | +3.6% |
| Feb 4, 2025 | +5.4% | +0.1% | +2.0% | +8.1% | +0.7% |
| Oct 30, 2024 | +9.2% | -0.1% | +1.0% | -11.4% | -11.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $6.29 | $5.62 | +11.9% | $10.05B |
| Apr 30, 2026 | $5.15 | $4.77 | +8.0% | $8.62B |
| Feb 3, 2026 | $5.29 | $4.73 | +11.8% | $9.87B |
| Nov 4, 2025 | $5.64 | $5.02 | +12.4% | $9.56B |
| Aug 5, 2025 | $6.02 | $5.28 | +14.0% | $9.17B |
| May 1, 2025 | $4.90 | $4.27 | +14.8% | $8.15B |
| Feb 4, 2025 | $5.31 | $5.04 | +5.4% | $9.09B |
| Oct 30, 2024 | $5.58 | $5.11 | +9.2% | $8.50B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 25.0× | 23.3× | 67th | Top 14% |
| P/E (forward) | 17.5× | — | — | — |
| EV / EBITDA | 15.8× | — | — | Top 19% |
| EV / Sales | 6.84× | — | — | Bottom 39% |
| Free-cash-flow yield | 4.68% | — | — | Top 19% |
| Earnings yield | 3.99% | — | — | Top 14% |
P/E over the past five years
Range 16.3× – 53.8× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +35.0%
- Earnings per share growth (TTM)
- +31.6%
- Change in P/E multiple
- +8.9%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 85
- 50-day average slope (20 days)
- +3.6%
- 200-day average slope (20 days)
- +1.8%
- Distance from 50-day average
- -1.6%
- Distance from 200-day average
- +10.6%
- RSI (14)
- 47.7
- Relative volume
- 1.08×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 34.9%
- Volatility vs own 5-year history
- 100th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.36
- Correlation with S&P 500
- 0.19
- Current drawdown from 1-year high
- -9.2%
- Maximum drawdown, 3 years
- -23.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 8, 2022 | Jun 1, 2023 | -26.7% | 140 days | 147 days (Jan 2, 2024) |
| Sep 20, 2024 | Jan 6, 2025 | -23.4% | 73 days | 213 days (Nov 11, 2025) |
| Apr 20, 2021 | Nov 30, 2021 | -23.3% | 156 days | 226 days (Oct 24, 2022) |
| Feb 1, 2024 | Apr 18, 2024 | -19.0% | 53 days | 57 days (Jul 11, 2024) |
| Feb 27, 2026 | May 4, 2026 | -16.6% | 45 days | 58 days (Jul 28, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $217.52B
- P/E (TTM)
- 25.0
- EPS, diluted (TTM)
- $16.09
- Revenue (TTM)
- $38.13B
- Dividend yield
- 2.47%
- 52-week range
- $288.00 – $447.03
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $25.98B | $26.32B | $28.19B | $33.42B | $36.74B |
| Gross profit | $19.52B | $19.92B | $19.77B | $20.57B | $26.01B |
| Operating income | $7.64B | $9.57B | $7.90B | $7.26B | $10.68B |
| Net income | $5.89B | $6.55B | $6.72B | $4.09B | $7.71B |
| EPS (diluted) | $10.28 | $12.11 | $12.49 | $7.56 | $14.23 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.50B | $9.09B | $8.15B | $9.17B | $9.56B | $9.90B | $8.62B | $10.05B |
| Net income | $2.83B | $627.0M | $1.73B | $1.43B | $3.22B | $1.33B | $1.82B | $2.38B |
| EPS (diluted) | $5.22 | $1.16 | $3.20 | $2.65 | $5.93 | $2.45 | $3.34 | $4.37 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $9.26B | $9.72B | $8.47B | $11.49B | $9.96B |
| Capital expenditure | -$880.0M | -$936.0M | -$1.11B | -$1.10B | -$1.86B |
| Free cash flow | $8.38B | $8.79B | $7.36B | $10.39B | $8.10B |
| Dividends paid | -$4.01B | -$4.20B | -$4.56B | -$4.83B | -$5.12B |
| Net share buybacks | -$4.97B | -$6.36B | $0 | -$200.0M | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $13.99B
- Total assets
- $95.64B
- Total liabilities
- $83.95B
- Total debt
- $57.30B
- Net debt
- $43.31B
- Shareholders’ equity
- $11.69B
As of Jun 30, 2026 (filed Aug 5, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 21, 2026 | $2.52 | Sep 11, 2026 |
| May 15, 2026 | $2.52 | Jun 5, 2026 |
| Feb 13, 2026 | $2.52 | Mar 6, 2026 |
| Nov 21, 2025 | $2.38 | Dec 12, 2025 |
| Aug 22, 2025 | $2.38 | Sep 12, 2025 |
| May 16, 2025 | $2.38 | Jun 6, 2025 |
| Feb 14, 2025 | $2.38 | Mar 7, 2025 |
| Nov 18, 2024 | $2.25 | Dec 9, 2024 |
Short interest
- Shares sold short
- 14,063,517
- Days to cover
- 4.94
- Change vs previous report
- +8.4%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 22, 1999
- 2-for-1
- Mar 1, 1999
- 2-for-1
- Aug 16, 1995
- 2-for-1
- Sep 11, 1991
- 3-for-1
- Aug 13, 1990
- 2-for-1